NDC 67850-141

Asclera

Polidocanol

Asclera is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Methapharm, Inc. The primary component is Polidocanol.

• Product ID: 67850-141_ed77119d-3a51-48d9-ad3f-d5320103ed6f
• NDC: 67850-141
• Product Type: Human Prescription Drug
• Proprietary Name: Asclera
• Generic Name: Polidocanol
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2010-06-01
• Marketing Category: NDA /
• Application Number: NDA021201
• Labeler Name: Methapharm, Inc
• Substance Name: POLIDOCANOL
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Sclerosing Agent [EPC],Sclerosing Activity [MoA],Vascular Sclerosing Activity [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 67850-141-05

2 mL in 1 AMPULE (67850-141-05)

• Marketing Start Date: 2022-02-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Asclera" or generic name "Polidocanol"

NDC	Brand Name	Generic Name
46783-121	Asclera	POLIDOCANOL
46783-221	Asclera	POLIDOCANOL
67850-140	Asclera	POLIDOCANOL
67850-141	Asclera	POLIDOCANOL
60635-107	Varithena	polidocanol
60635-111	Varithena	polidocanol
60635-118	Varithena	polidocanol
60635-123	Varithena	polidocanol
60635-133	Varithena	polidocanol